TIGIT and neoplasm: Hereby, the results of Preillon et al. provide an interesting insight into a tumor-specific T-cell function within TIGIT-antibody treatment: TIGIT-expressing TILS were shown to have impaired antitumor activity; however, TIGIT antibody treatment was able to potently reverse these effects in vitro [40].